All posts tagged
French Biotech gets an EU CRISPR Patent for CAR-T Research
UPDATE: The First Off-the-Shelf CAR-T Cancer Therapy has Entered the Clinic
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
Europe’s Lag in the Gene Editing Race may leave its Biotech Obsolete
Would you Taste this Gene-Edited Dinner?
Cellectis’ CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”
Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer
Cellectis will work from New York to become a CAR-T leader
Labiotech UG, All Rights Reserved -
Send this to friend